These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2446063)

  • 41. [Neuroleptics and serotonin].
    Hery F; Hamon M
    Encephale; 1993; 19(5):525-32. PubMed ID: 7905821
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of alpha-adrenergic blockade in the cardiovascular actions of ketanserin: studies in patients with essential hypertension, autonomic insufficiency, and Raynaud's phenomenon.
    Brouwer RM; Wenting GJ; Man in't Veld AJ; Schalekamp MA
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S26-31. PubMed ID: 2446064
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.
    Massot O; Rousselle JC; Fillion MP; Grimaldi B; Cloëz-Tayarani I; Fugelli A; Prudhomme N; Seguin L; Rousseau B; Plantefol M; Hen R; Fillion G
    Mol Pharmacol; 1996 Oct; 50(4):752-62. PubMed ID: 8863819
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 5-hydroxytryptamine: considerations about discovery, receptor classification and relevance to medical research.
    Villalón CM; Terrón JA; Ramírez-San Juan E; Saxena PR
    Arch Med Res; 1995; 26(4):331-44. PubMed ID: 8555727
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Serotonin-2 receptor-mediated intraplatelet calcium mobilization in affective disorders: relevance to the pathophysiology of depression].
    Kusumi I
    Hokkaido Igaku Zasshi; 1993 May; 68(3):325-36. PubMed ID: 8319932
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 5-HT1B receptors and aggression: a review.
    Olivier B; van Oorschot R
    Eur J Pharmacol; 2005 Dec; 526(1-3):207-17. PubMed ID: 16310769
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The central or peripheral nature of pain in essential headaches].
    Sicuteri F; Fonda C
    Minerva Med; 1976 Jun; 67(28):1826-33. PubMed ID: 180458
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serotonergic mechanisms in hypertension.
    Chandra M; Chandra N
    Int J Cardiol; 1993 Dec; 42(3):189-96. PubMed ID: 8138327
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of serotonin in cardiovascular disease.
    Frohlich ED
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S1-2. PubMed ID: 2446053
    [No Abstract]   [Full Text] [Related]  

  • 50. Serotonin and acute cardiovascular disorders.
    Reneman RS; van der Starre PJ
    Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():19-25. PubMed ID: 2285646
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serotonin: from top to bottom.
    Fidalgo S; Ivanov DK; Wood SH
    Biogerontology; 2013 Feb; 14(1):21-45. PubMed ID: 23100172
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [VIII International Conference <« Systemic Circulation, Microcirculation And Haemorheology> (from angiogenesis to central circulation)].
    Shilkina NP
    Angiol Sosud Khir; 2012; 18(1):33-7. PubMed ID: 22866343
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serotonin in cardiovascular regulation. Satellite symposium to the 11th International Society of Hypertension meeting. Heidelberg, Federal Republic of Germany, September 6, 1986. Proceedings.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S1-S137. PubMed ID: 2446052
    [No Abstract]   [Full Text] [Related]  

  • 54. [Subtypes and function of serotonin].
    Takata M
    Nihon Rinsho; 2000 Jan; 58 Suppl 1():94-7. PubMed ID: 11026243
    [No Abstract]   [Full Text] [Related]  

  • 55. Exploring the Role of Serotonin as an Immune Modulatory Component in Cardiovascular Diseases.
    Imamdin A; van der Vorst EPC
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675065
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Research progress on the role of 5-hydroxytryptamine in cardiovascular diseases].
    Lu N; Chi YP; Tao SH; Liu MY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Feb; 51(2):208-214. PubMed ID: 36789604
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Venlafaxine-Induced Bruising: A Case Report.
    Carpenter JE; Fombi J; Udoka O; Holder-Perkins V
    Prim Care Companion CNS Disord; 2016; 18(3):. PubMed ID: 27722026
    [No Abstract]   [Full Text] [Related]  

  • 58. Use of Selective Serotonin Reuptake Inhibitors and Risks of Stroke in Patients with Obsessive Compulsive Disorder: A Population-Based Study.
    Chu CS; Chou PH; Lin CH; Cheng C; Tsai CJ; Lan TH; Huang MW; Nestadt G
    PLoS One; 2016; 11(9):e0162239. PubMed ID: 27612144
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of 5-hydroxytryptamine receptors mediating contractions in basilar arteries from stroke-prone spontaneously hypertensive rats.
    Nishimura Y
    Br J Pharmacol; 1996 Mar; 117(6):1325-1333. PubMed ID: 8882632
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pathophysiological relevance of serotonin.
    van Zwieten PA
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S19-25. PubMed ID: 2446063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.